Cargando…

Improved inherited peripheral neuropathy genetic diagnosis by whole-exome sequencing

Inherited peripheral neuropathies (IPNs) are a group of related diseases primarily affecting the peripheral motor and sensory neurons. They include the hereditary sensory neuropathies (HSN), hereditary motor neuropathies (HMN), and Charcot-Marie-Tooth disease (CMT). Using whole-exome sequencing (WES...

Descripción completa

Detalles Bibliográficos
Autores principales: Drew, Alexander P, Zhu, Danqing, Kidambi, Aditi, Ly, Carolyn, Tey, Shelisa, Brewer, Megan H, Ahmad-Annuar, Azlina, Nicholson, Garth A, Kennerson, Marina L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4367087/
https://www.ncbi.nlm.nih.gov/pubmed/25802885
http://dx.doi.org/10.1002/mgg3.126
_version_ 1782362485085437952
author Drew, Alexander P
Zhu, Danqing
Kidambi, Aditi
Ly, Carolyn
Tey, Shelisa
Brewer, Megan H
Ahmad-Annuar, Azlina
Nicholson, Garth A
Kennerson, Marina L
author_facet Drew, Alexander P
Zhu, Danqing
Kidambi, Aditi
Ly, Carolyn
Tey, Shelisa
Brewer, Megan H
Ahmad-Annuar, Azlina
Nicholson, Garth A
Kennerson, Marina L
author_sort Drew, Alexander P
collection PubMed
description Inherited peripheral neuropathies (IPNs) are a group of related diseases primarily affecting the peripheral motor and sensory neurons. They include the hereditary sensory neuropathies (HSN), hereditary motor neuropathies (HMN), and Charcot-Marie-Tooth disease (CMT). Using whole-exome sequencing (WES) to achieve a genetic diagnosis is particularly suited to IPNs, where over 80 genes are involved with weak genotype–phenotype correlations beyond the most common genes. We performed WES for 110 index patients with IPN where the genetic cause was undetermined after previous screening for mutations in common genes selected by phenotype and mode of inheritance. We identified 41 missense sequence variants in the known IPN genes in our cohort of 110 index patients. Nine variants (8%), identified in the genes MFN2, GJB1, BSCL2, and SETX, are previously reported mutations and considered to be pathogenic in these families. Twelve novel variants (11%) in the genes NEFL, TRPV4, KIF1B, BICD2, and SETX are implicated in the disease but require further evidence of pathogenicity. The remaining 20 variants were confirmed as polymorphisms (not causing the disease) and are detailed here to help interpret sequence variants identified in other family studies. Validation using segregation, normal controls, and bioinformatics tools was valuable as supporting evidence for sequence variants implicated in disease. In addition, we identified one SETX sequence variant (c.7640T>C), previously reported as a putative mutation, which we have confirmed as a nonpathogenic rare polymorphism. This study highlights the advantage of using WES for genetic diagnosis in highly heterogeneous diseases such as IPNs and has been particularly powerful in this cohort where genetic diagnosis could not be achieved due to phenotype and mode of inheritance not being previously obvious. However, first tier testing for common genes in clinically well-defined cases remains important and will account for most positive results.
format Online
Article
Text
id pubmed-4367087
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BlackWell Publishing Ltd
record_format MEDLINE/PubMed
spelling pubmed-43670872015-03-23 Improved inherited peripheral neuropathy genetic diagnosis by whole-exome sequencing Drew, Alexander P Zhu, Danqing Kidambi, Aditi Ly, Carolyn Tey, Shelisa Brewer, Megan H Ahmad-Annuar, Azlina Nicholson, Garth A Kennerson, Marina L Mol Genet Genomic Med Original Articles Inherited peripheral neuropathies (IPNs) are a group of related diseases primarily affecting the peripheral motor and sensory neurons. They include the hereditary sensory neuropathies (HSN), hereditary motor neuropathies (HMN), and Charcot-Marie-Tooth disease (CMT). Using whole-exome sequencing (WES) to achieve a genetic diagnosis is particularly suited to IPNs, where over 80 genes are involved with weak genotype–phenotype correlations beyond the most common genes. We performed WES for 110 index patients with IPN where the genetic cause was undetermined after previous screening for mutations in common genes selected by phenotype and mode of inheritance. We identified 41 missense sequence variants in the known IPN genes in our cohort of 110 index patients. Nine variants (8%), identified in the genes MFN2, GJB1, BSCL2, and SETX, are previously reported mutations and considered to be pathogenic in these families. Twelve novel variants (11%) in the genes NEFL, TRPV4, KIF1B, BICD2, and SETX are implicated in the disease but require further evidence of pathogenicity. The remaining 20 variants were confirmed as polymorphisms (not causing the disease) and are detailed here to help interpret sequence variants identified in other family studies. Validation using segregation, normal controls, and bioinformatics tools was valuable as supporting evidence for sequence variants implicated in disease. In addition, we identified one SETX sequence variant (c.7640T>C), previously reported as a putative mutation, which we have confirmed as a nonpathogenic rare polymorphism. This study highlights the advantage of using WES for genetic diagnosis in highly heterogeneous diseases such as IPNs and has been particularly powerful in this cohort where genetic diagnosis could not be achieved due to phenotype and mode of inheritance not being previously obvious. However, first tier testing for common genes in clinically well-defined cases remains important and will account for most positive results. BlackWell Publishing Ltd 2015-03 2015-01-14 /pmc/articles/PMC4367087/ /pubmed/25802885 http://dx.doi.org/10.1002/mgg3.126 Text en © 2015 The Authors. Molecular Genetics & Genomic Medicine published by Wiley Periodicals, Inc. http://creativecommons.org/licenses/by/4.0/ This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Drew, Alexander P
Zhu, Danqing
Kidambi, Aditi
Ly, Carolyn
Tey, Shelisa
Brewer, Megan H
Ahmad-Annuar, Azlina
Nicholson, Garth A
Kennerson, Marina L
Improved inherited peripheral neuropathy genetic diagnosis by whole-exome sequencing
title Improved inherited peripheral neuropathy genetic diagnosis by whole-exome sequencing
title_full Improved inherited peripheral neuropathy genetic diagnosis by whole-exome sequencing
title_fullStr Improved inherited peripheral neuropathy genetic diagnosis by whole-exome sequencing
title_full_unstemmed Improved inherited peripheral neuropathy genetic diagnosis by whole-exome sequencing
title_short Improved inherited peripheral neuropathy genetic diagnosis by whole-exome sequencing
title_sort improved inherited peripheral neuropathy genetic diagnosis by whole-exome sequencing
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4367087/
https://www.ncbi.nlm.nih.gov/pubmed/25802885
http://dx.doi.org/10.1002/mgg3.126
work_keys_str_mv AT drewalexanderp improvedinheritedperipheralneuropathygeneticdiagnosisbywholeexomesequencing
AT zhudanqing improvedinheritedperipheralneuropathygeneticdiagnosisbywholeexomesequencing
AT kidambiaditi improvedinheritedperipheralneuropathygeneticdiagnosisbywholeexomesequencing
AT lycarolyn improvedinheritedperipheralneuropathygeneticdiagnosisbywholeexomesequencing
AT teyshelisa improvedinheritedperipheralneuropathygeneticdiagnosisbywholeexomesequencing
AT brewermeganh improvedinheritedperipheralneuropathygeneticdiagnosisbywholeexomesequencing
AT ahmadannuarazlina improvedinheritedperipheralneuropathygeneticdiagnosisbywholeexomesequencing
AT nicholsongartha improvedinheritedperipheralneuropathygeneticdiagnosisbywholeexomesequencing
AT kennersonmarinal improvedinheritedperipheralneuropathygeneticdiagnosisbywholeexomesequencing